Publication | Open Access
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
46
Citations
21
References
2013
Year
In compensated patients with advanced fibrosis due to HCV-1, triple therapy with TVR led to satisfactory rates of safety, tolerability and on-treatment virological response with adequate managements of AEs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1